CannabisScienceFacts.com

Conditions How we grade About Glossary →

Facts / Evidence grade

Strong evidence

38 facts graded strong. Convergent evidence: controlled trials, systematic reviews, or long-established pharmacology.

Strong 38 Moderate 15 Limited 3 Mixed 6

Your body makes its own cannabinoidsHumans produce endocannabinoids — anandamide (named from the Sanskrit "ananda", bliss) and 2-AG — which activate the same receptors as plant THC. The system was discovered because THC worked, not the other way around: researchers found the receptor first (1988), then asked why it existed.Strong
CB1 is among the most abundant receptors in the human brainCB1 receptors are expressed at densities rivaling glutamate and GABA receptors across the cortex, hippocampus, basal ganglia and cerebellum. Their density in movement and memory regions explains both the therapeutic reach of cannabinoids and their side-effect profile.Strong
The endocannabinoid system helps regulate appetite, pain, mood and memoryThe ECS is a homeostatic signaling system: it tunes hunger, pain signaling, stress response, sleep and memory consolidation. It works "on demand" — synthesized when needed, broken down quickly by enzymes (FAAH, MAGL). This is why cannabis touches so many functions at once.Strong
CB2 receptors live mostly in your immune systemWhile CB1 dominates the brain, CB2 receptors concentrate in immune cells and peripheral tissues, modulating inflammation. CB2 is the main reason researchers believe cannabinoids could have anti-inflammatory effects without a high.Strong
THC was first isolated in 1964Raphael Mechoulam's team in Israel isolated and synthesized Δ9-THC in 1964 — and CBD a year earlier. Despite cannabis being used for millennia, its chemistry is a modern discovery: younger than the Beatles.Strong
THC is only a partial agonist — it presses the receptor gentlyTHC partially activates CB1 receptors rather than fully switching them on. This partial activity is one reason cannabis has a wide safety margin compared to full-agonist synthetic cannabinoids ("spice"), which can be lethal — a critical distinction often lost in public debate.Strong
Cannabis potency has risen dramatically over 50 yearsUS potency-monitoring data shows average THC in seized cannabis rising from ~2% in the 1970s–80s to well above 12–15% in recent years, with concentrates reaching 60–90%. "Cannabis today" and "cannabis in the studies from 1985" are not the same exposure.Strong
Edibles feel stronger because your liver makes a stronger moleculeEaten THC passes the liver first, where it converts to 11-hydroxy-THC — a metabolite that crosses the blood-brain barrier more efficiently and is more potent per milligram. This is pharmacology, not imagination, and why the same milligrams hit harder eaten than smoked.Strong
A positive drug test says nothing about being high right nowTHC metabolites are fat-soluble and linger for days (occasional use) to weeks (daily use) in urine. Roadside and workplace tests detect exposure, not impairment — one of the hardest unsolved problems in cannabis policy.Strong
CBD does not make you highCBD does not meaningfully activate CB1 receptors and produces no intoxication at normal doses. WHO's Expert Committee on Drug Dependence concluded CBD shows no abuse or dependence potential. "Cannabis without the high" is, for CBD alone, accurate.Strong
CBD is an approved medicine for severe childhood epilepsyPurified CBD (Epidiolex) is FDA- and EMA-approved for Dravet syndrome, Lennox-Gastaut syndrome and TSC-related seizures, cutting seizure frequency in randomized controlled trials. This is the gold standard of cannabinoid evidence: real RCTs, real approval.Strong
CBD products are frequently mislabeledA landmark JAMA study testing 84 online CBD products found only ~31% accurately labeled; many under-delivered CBD, and 21% contained unlabeled THC. Regulated markets with lab testing largely fix this — unregulated ones do not.Strong
CBD interacts with common medications — the "grapefruit rule" appliesCBD inhibits CYP450 enzymes (notably CYP3A4 and CYP2C19) that metabolize many drugs: blood thinners, anti-epileptics, some antidepressants. If a medication carries a grapefruit warning, treat CBD the same way and ask a pharmacist.Strong
Cannabis terpenes are not unique to cannabisMyrcene is in mangoes and hops, limonene in citrus peel, pinene in pine, linalool in lavender. Cannabis is remarkable for combining dozens of them in one flower — not for owning them. This is why strain aromas map so well onto other plants.Strong
Beta-caryophyllene is a dietary cannabinoidThe peppery terpene β-caryophyllene — also in black pepper and cloves — directly activates CB2 receptors. It is the best-documented case of a terpene acting like a cannabinoid, demonstrated by Gertsch et al. in 2008.Strong
Edibles take 30–120 minutes — and that delay causes the overdosesPeak effects from edibles arrive far later than smoking (minutes). The classic bad experience is re-dosing at minute 45 because "nothing happened" — then both doses land together. The single most protective rule with edibles is: wait two full hours before taking more.Strong
Secondhand cannabis smoke can produce detectable exposure — in extreme conditionsStudies sealing non-smokers in small unventilated chambers with heavy smoke produced detectable THC metabolites and mild effects. In ventilated real-world conditions, positives were rare and below standard testing thresholds. The "contact high" is real but requires genuinely extreme exposure.Strong
THC impairs driving — measurably and dose-dependentlyControlled on-road and simulator studies show THC worsens lane weaving, reaction time and divided attention, roughly doubling crash risk at typical recreational doses. Combining with alcohol multiplies impairment well beyond either alone.Strong
You can be impaired after you stop feeling highStudies tracking performance show measurable impairment persisting after subjective effects fade — especially with edibles, where performance deficits can extend 6–8+ hours. Feeling fine is not a reliable test of being fine.Strong
Cannabis use disorder is real — about 1 in 10 users, 1 in 3 daily usersCannabis can produce a clinically defined dependence: cravings, failed cut-downs, use despite harm, and a recognized withdrawal syndrome (irritability, insomnia, appetite loss). Risk rises steeply with daily use and early initiation. "Non-addictive" is marketing, not science.Strong
Cannabinoid hyperemesis syndrome: the paradoxical vomiting illnessSome long-term heavy users develop CHS — cyclic severe vomiting that, paradoxically, is relieved by hot showers and resolves only with cannabis cessation. It is frequently misdiagnosed for years. If this sounds like you or a patient, the literature is now clear.Strong
Daily high-potency use is associated with increased psychosis riskThe multi-site EU-GEI study (Lancet Psychiatry, 2019) found daily users of high-potency cannabis (>10% THC) had ~5× the odds of a psychotic disorder, with population-level impact measurable in cities like Amsterdam and London. Association is firmly established; individual susceptibility varies — family history of psychosis is the key red flag.Strong
There is no documented case of a fatal overdose from THC aloneCB1 receptors are sparse in the brainstem centers controlling breathing — unlike opioid receptors — which is why THC does not stop respiration even at extreme doses. The real acute dangers are psychiatric (panic, psychosis), cardiac stress in vulnerable people, and injury while impaired — especially children and edibles.Strong
Medical bodies agree: avoid cannabis in pregnancy and breastfeedingACOG and pediatric associations recommend against use: THC crosses the placenta and concentrates in breast milk, and studies link prenatal exposure to lower birth weight and attention effects in children. THC stored in body fat can persist in milk for weeks.Strong
The strongest medical evidence: chronic pain, MS spasticity, chemo nauseaThe landmark 2017 National Academies report — the most rigorous evidence review to date — found substantial evidence for only three indications: chronic pain in adults, chemotherapy-induced nausea (oral cannabinoids), and MS-related spasticity. Nearly everything else sits at "limited" or "insufficient."Strong
Cannabinoid medicines are already in the pharmacyDronabinol and nabilone (synthetic THC) are approved for chemo nausea and AIDS wasting; nabiximols (THC+CBD spray) is approved for MS spasticity in 25+ countries; Epidiolex (CBD) for severe epilepsy. The medical channel exists and works — it is simply narrower than the dispensary menu suggests.Strong
Cannabis is not a proven cancer treatmentCannabinoids kill cancer cells in petri dishes and mice — as do thousands of compounds that never become medicines. No controlled human trial has shown cannabis treating cancer. It genuinely helps with chemo nausea and appetite; abandoning oncology treatment for cannabis has cost lives.Strong
Endocannabinoid receptors are in your gut, skin, liver and bones — not just your brainCB1 and CB2 receptors, plus the enzymes that make and destroy endocannabinoids, are expressed across the gastrointestinal tract, skin, liver, fat tissue and bone. The ECS is a whole-body regulatory network, which is why cannabinoid research now spans IBS, eczema, liver disease and osteoporosis.Strong
THC hides in your fat cells and leaks out for weeksTHC is highly lipophilic: after use it partitions into body fat and redistributes slowly back into blood. This storage-and-release cycle is why urine tests can stay positive for weeks after the last use — and why heavy users can show measurable blood THC days into abstinence.Strong
Your body absorbs only a fraction of the CBD you swallowOral CBD has bioavailability around 6–13%: the liver metabolizes most of it before it reaches circulation. Taking it with a fatty meal can multiply absorption several-fold. Two identical capsules can produce wildly different blood levels depending on lunch.Strong
High-dose CBD can stress the liver — the trials measured itIn the Epidiolex epilepsy trials, a meaningful share of patients on high-dose CBD (10–20 mg/kg/day) showed elevated liver transaminases, especially with valproate. This is why the label requires liver monitoring — and why megadose self-experimentation is not harmless.Strong
Shop CBD doses are a rounding error next to trial dosesHuman studies showing CBD effects typically use 300–600 mg per day, sometimes more. Over-the-counter products commonly suggest 5–25 mg. Whatever you believe about CBD's potential, most consumer products deliver a small fraction of studied doses — expectations should scale accordingly.Strong
"Start low, go slow" is not a slogan — it is dose-response pharmacologyAdverse effects of THC — anxiety, tachycardia, dizziness, impairment — scale with dose and peak blood level, and edibles add unpredictable absorption on top. Starting at 2.5–5 mg and waiting the full onset window before redosing is how you stay on the friendly side of the curve.Strong
Your CB1 receptors recover after you stop — brain scans show itChronic cannabis use downregulates CB1 receptors, a biological basis of tolerance. PET imaging studies show cortical CB1 availability rebounding toward normal after about four weeks of abstinence. Tolerance is real — and so is its reversal.Strong
Alcohol plus cannabis is worse than either alone behind the wheelCombined use multiplies lane weaving, reaction-time and divided-attention deficits in simulator and on-road studies, and crash-risk analyses find the combination riskier than either substance by itself. "Only a little of each" is not a safe strategy.Strong
THC acutely raises heart rate — a real caution for cardiac patientsTHC increases resting heart rate by 20–50 beats per minute in the first hour after use and can trigger ischemia in susceptible people; registry studies link the post-use hour to elevated heart-attack risk in vulnerable users. Healthy hearts tolerate it; diseased ones deserve respect.Strong
The most predictable danger is not the plant — it is what is on itTesting programs repeatedly find pesticides, heavy metals, residual solvents and mold in unregulated market products, and the 2019 EVALI lung-injury outbreak was traced to vitamin E acetate in illicit vape carts — thousands hospitalized, dozens dead. Lab-tested, regulated supply is a genuine safety feature, not bureaucracy.Strong
A THC medicine has been FDA-approved since 1985Dronabinol (Marinol) — synthetic THC — was approved four decades ago for chemotherapy-induced nausea and AIDS-related appetite loss, later joined by nabilone. Whatever the plant's legal status, cannabinoid medicine itself is old, established pharmacology.Strong

How we grade evidence